Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer.
Publication
, Conference
Havrilesky, LJ; Hanna, RK; Poniewierski, MS; Laskey, R; Secord, AA; Gehrig, PA; Lopez, MA; Shafer, A; Van Le, L; Dale, DC; Crawford, J; Lyman, GH
Published in: Journal of Clinical Oncology
May 20, 2011
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2011
Volume
29
Issue
15_suppl
Start / End Page
5084 / 5084
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Havrilesky, L. J., Hanna, R. K., Poniewierski, M. S., Laskey, R., Secord, A. A., Gehrig, P. A., … Lyman, G. H. (2011). Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer. In Journal of Clinical Oncology (Vol. 29, pp. 5084–5084). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2011.29.15_suppl.5084
Havrilesky, L. J., R. K. Hanna, M. S. Poniewierski, R. Laskey, A. A. Secord, P. A. Gehrig, M. A. Lopez, et al. “Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer.” In Journal of Clinical Oncology, 29:5084–5084. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.5084.
Havrilesky LJ, Hanna RK, Poniewierski MS, Laskey R, Secord AA, Gehrig PA, et al. Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 5084–5084.
Havrilesky, L. J., et al. “Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer.” Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2011, pp. 5084–5084. Crossref, doi:10.1200/jco.2011.29.15_suppl.5084.
Havrilesky LJ, Hanna RK, Poniewierski MS, Laskey R, Secord AA, Gehrig PA, Lopez MA, Shafer A, Van Le L, Dale DC, Crawford J, Lyman GH. Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 5084–5084.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2011
Volume
29
Issue
15_suppl
Start / End Page
5084 / 5084
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences